Stem cell therapy ‘sold as a miracle cure’ linked to 17 bacterial hospitalizations

2-28-2019 unnamed file
Image credit: Liveyon
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Over the past year, at least 17 people have been hospitalized after being injected with products made from umbilical cord blood, a little-known but fast-growing segment of the booming stem cell industry, according to state and federal health officials and patient reports. Sold as a miracle cure for a variety of in­trac­table conditions, the injections have sickened people in five states, prompting new warnings from health officials about the risks of unproven stem cell treatments.

All but two of the illnesses have been linked to a single company: Liveyon of Yorba Linda, Calif.

After obtaining 10 unopened vials of Liveyon treatments from clinics in Texas and Florida where patients had fallen ill, the CDC report said, investigators found bacteria in eight of them. In the weeks since then, CDC officials said, they have obtained many more ReGen vials directly from Liveyon and found bacteria in a large proportion of them.

Related article:  ‘Young blood’ plasma treatments unproven, possibly dangerous, says FDA

“We’re just the tip of the iceberg, and we’re the cleanest in the iceberg,” [Liveyon CEO John] Kosolcharoen said. “If anyone else knew what’s going on in this industry, they would roll over in their grave.”

Read full, original post: ‘Miraculous’ stem cell therapy has sickened people in five states

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend